EN HU

Halmi Sándor

Halmi Sándor

Teljes publikációs lista

2024
1.
Berta, E., Halmi, S., Molnár, I., Hutkai, D., Csiha, S., Bhattoa, H. P., Lőrincz, H., Somodi, S., Katkó, M., Harangi, M., Paragh, G., Nagy, E. V., Bodor, M.: Low Serum Fibroblast Growth Factor 21 Level and Its Altered Regulation by Thyroid Hormones in Patients with Hashimoto's Thyroiditis on Levothyroxine Substitution.
Metabolites. 14 (10), 1-10, (cikkazonosító: 565), 2024.
Folyóirat-mutatók:
Q2 Biochemistry
Q2 Endocrinology, Diabetes and Metabolism
Q2 Molecular Biology
2.
Halmi, S., Berta, E., Diószegi, Á., Sira, L., Fülöp, P., Nagy, E. V., Győry, F., Kanyári, Z., Tóth, J., Bhattoa, H. P., Bodor, M.: Single center experience in localization of insulinoma by selective intraarterial calcium stimulation angiography: a case series of 15 years.
Front Endocrinol (Lausanne). 15, 1-7, (cikkazonosító: 1305958), 2024.
Folyóirat-mutatók:
Q1 Endocrinology, Diabetes and Metabolism
2023
3.
Csiha, S., Molnár, I., Halmi, S., Hutkai, D., Lőrincz, H., Somodi, S., Katkó, M., Harangi, M., Paragh, G., Nagy, E. V., Berta, E., Bodor, M.: Advanced glycation end products and their soluble receptor (sRAGE) in patients with Hashimoto's thyroiditis on levothyroxine substitution.
Front. Endocrinol. 14, 1-9, (cikkazonosító: 1187725), 2023.
Folyóirat-mutatók:
Q1 Endocrinology, Diabetes and Metabolism
4.
Gál, K., Halmi, S., Németh, N., Gálné Remenyik, J., Soltész, P.: Monitoring and recovery of hyperglicaemia-induced endothelial dysfunction with rheopheresis in diabetic lower extremity ulceration with hyperviscosity.
Diabetes Technol. Ther. 25 (Suppl.), A-200, 2023.
2022
5.
Csiha, S., Halmi, S., Hutkai, D., Molnár, I., Katkó, M., Lőrincz, H., Harangi, M., Paragh, G., Nagy, E. V., Bodor, M., Berta, E.: Association of chemerin and serum advanced glycation end products in patients with autoimmune thyroiditis.
EJEA. 81, EP400, 2022.
6.
Lengyel, I., Halmi, S., Lőrincz, H., Csiha, S., Katkó, M., Harangi, M., Nagy, E. V., Paragh, G., Bodor, M., Berta, E.: Characterization of fetuin-A levels in patients with autoimmune thyroid disease.
Atherosclerosis. 355, e247-e248, 2022.
7.
Gál, K., Veres, K., Halmi, S., Bozoki-Beke, K., Fekete, K., Homoki, J., Gálné Remenyik, J., Baráth, B., Varga, Á., Németh, N., Soltész, P.: The effect of rheopheresis treatment on the cytokine profile in diabetic foot syndrome with hyperviscosity in the aspect of clinical changes: a preliminary study.
Clin. Hemorheol. Microcirc. 80 (2), 117-125, 2022.
Folyóirat-mutatók:
Q3 Cardiology and Cardiovascular Medicine
Q3 Hematology
Q3 Physiology
Q3 Physiology (medical)
2021
8.
Szilágyi, B., Fejes, Z., Rusznyák, Á., Fenyvesi, F., Pócsi, M., Halmi, S., Griger, Z., Kunapuli, S. P., Kappelmayer, J., Nagy, B. J.: Platelet Microparticles Enriched in miR-223 Reduce ICAM-1-Dependent Vascular Inflammation in Septic Conditions.
Front. Physiol. 12, 1-14, 2021.
Folyóirat-mutatók:
Q1 Physiology
Q1 Physiology (medical)
9.
Berta, E., Bodor, M., Halmi, S., Lengyel, I., Diószegi, Á., Katkó, M., Seres, I., Nagy, E. V., Paragh, G., Harangi, M.: Strong correlations between serum fibroblast growth factor 21 level and lipid parameters in patients with autoimmune thyroiditis.
Atherosclerosis. 331, e201, 2021.
2019
10.
Berta, E., Lengyel, I., Halmi, S., Puskás, I., Felszeghy, E. N., Balogh, Z., Nagy, E. V., Bodor, M.: Control of hyperglycemia in a young male patient with gigantism during transition: a case report.
Endocrine Abstracts. 63, P719, 2019.
11.
Berta, E., Lengyel, I., Halmi, S., Zrínyi, M., Erdei, A., Harangi, M., Páll, D., Nagy, E. V., Bodor, M.: Hypertension in thyroid disorders.
Front Endocrinol (Lausanne). 10, 1-11, 2019.
Folyóirat-mutatók:
Q1 Endocrinology, Diabetes and Metabolism
2015
12.
Berta, E., Ujhelyi, B., Szabados, L., Galuska, L., Erdei, A., Gazdag, A., Halmi, S., Nagy, E. V., Bodor, M.: There is a detectable immune activity in the orbits of all patients diagnosed with Graves' regardless of later development of Graves' orbitopathy.
Endocrine Abstracts. 37, GP, 2015.
DEENK Debreceni Egyetem
© 2012 Debreceni Egyetem